Atrophic vaginitis: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) No edit summary |
||
| Line 45: | Line 45: | ||
===Physical Examination=== | ===Physical Examination=== | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
===CT=== | ===CT=== | ||
===MRI=== | |||
===Ultrasound=== | |||
===Other Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | |||
===Primary Prevention=== | |||
===Secondary Prevention=== | |||
==Cost-Effectiveness of Therapy== | |||
==Future or Investigational Therapies== | |||
==Case Studies== | ==Case Studies== | ||
Revision as of 16:25, 21 October 2016
For patient information, click here
| Atrophic vaginitis | |
| ICD-10 | N95.2 |
|---|---|
| ICD-9 | 627.3 |
| DiseasesDB | 32516 |
| MedlinePlus | 000892 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Synonyms and keywords: Atrophic vulvovaginitis; vaginal atrophy; urogenital atrophy; genitourinary syndrome of menopause
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Atrophic vaginitis from other Diseases
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Atrophic vaginitis case study one|Case#1